GME
GameStop Corp.
GME offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
TXRH
Texas Roadhouse, Inc.
TXRH has the edge over GME overall, supported by lower modeled downside and stronger modeled upside.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
TXRH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
TXRH's revenue, profitability, cash flow and balance sheet are all currently healthy.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME has the edge over TXRH in the historical PE scenario, which offers more potential upside but is not a forecast.
TXRH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $158 | -15% |
| Fair | 28x | $177 | -4.7% |
| Current | 29x | $186 | — |
| Expensive | 34x | $219 | +18% |
Historical ranges are pointers, not guarantees.
TXRH's PE is in its fair range at 29x.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
TXRH Forward outlook
There aren't enough analyst estimates for TXRH to show an outlook.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME has the edge over TXRH on earnings, with more consistent year-over-year improvement.
TXRH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $6.37 | -2.6% |
| Q2 2026 | $6.26 | -4.4% |
| Q1 2026 | $6.27 | -3.2% |
| Q4 2025 | $6.10 | -5.7% |
| Q3 2025 | $6.54 | +12% |
| Q2 2025 | $6.55 | +19% |
| Q1 2025 | $6.48 | +31% |
| Q4 2024 | $6.47 | +43% |
TXRH earned $6.37 per share over the past year, down 2.6% from the year before.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME has the edge over TXRH on profitability, with a higher operating margin.
TXRH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +9.5% |
| Q2 2026 | $1.7B | +11% |
| Q1 2026 | $1.6B | +13% |
| Q4 2025 | $1.5B | +3.1% |
| Q3 2025 | $1.4B | +13% |
| Q2 2025 | $1.5B | +13% |
| Q1 2025 | $1.4B | +9.6% |
| Q4 2024 | $1.4B | +23% |
TXRH has the edge over GME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.5% | -0.2 points |
| Q2 2026 | 8.5% | -1.2 points |
| Q1 2026 | 9% | -0.3 points |
| Q4 2025 | 6.5% | -3.1 points |
| Q3 2025 | 6.8% | -1.3 points |
| Q2 2025 | 9.7% | -1 points |
| Q1 2025 | 9.3% | -0.8 points |
| Q4 2024 | 9.6% | +2.5 points |
TXRH's operating margin was 6.5% last quarter, about level with the same quarter a year ago.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME has the edge over TXRH on cash flow, with more consistent year-over-year improvement.
TXRH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.1M | -25% |
| Q2 2026 | $81.5M | +128% |
| Q1 2026 | $178.9M | +12% |
| Q4 2025 | $131.3M | +1.2% |
| Q3 2025 | $14.7M | -69% |
| Q2 2025 | $35.7M | -36% |
| Q1 2025 | $160.4M | -3.3% |
| Q4 2024 | $129.7M | +82% |
TXRH generated $403M in free cash flow over the past year, up 18% from the year before.
GME Net Leverage
TXRH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
TXRH has more cash than debt.
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
TXRH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 47.9 | Neutral |
TXRH's weekly RSI is 54 (neutral) and its Stochastic is 48 (neutral).
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME has the edge over TXRH on valuation relative to its sector.
TXRH PE vs Consumer Cyclical Sector
| Metric | TXRH | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 18x | 62% above |
| PE % | 58 | 47 | 11 pts above |
TXRH is trading at 29x earnings, a 62% premium to the Consumer Cyclical sector's median of 18x.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME is in an uptrend: it's above all five of its weekly moving averages, and 17% above its 200-week average.
TXRH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $170.5 | 9.1% above |
| 20 week MA | $185.0 | 0.5% above |
| 50 week MA | $178.9 | 4% above |
| 100 week MA | $177.4 | 4.8% above |
| 200 week MA | $156.4 | 19% above |
TXRH is in an uptrend: it's above all five of its weekly moving averages, and 19% above its 200-week average.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME has the edge over TXRH on returns for 2026, with the stronger performance.
TXRH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $55.0 | $80.0 | +45% |
| 2021 | $80.0 | $88.8 | +11% |
| 2022 | $88.8 | $96.3 | +8.5% |
| 2023 | $96.3 | $122.2 | +27% |
| 2024 | $122.2 | $181.9 | +49% |
| 2025 | $181.9 | $170.8 | -6.1% |
| 2026 YTD | $170.8 | $186.0 | +8.9% |
TXRH has finished higher in five of the last six years. It's up 8.9% so far in 2026.